As shown in Table 2, patients in the non-survivor group were older, had lower diastolic blood pressure, total cholesterol, phosphate and higher FGF21, TACS, ATACS, AoACS, DTACS, and were more likely to have hypertension compared to those in the survivor group (p < 0.05). This evidence concerns the gene FGF21 and Hypertension.